345 related articles for article (PubMed ID: 3010361)
1. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
2. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
3. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade.
Leysen JE; Van Gompel P; de Chaffoy de Courcelles D; Niemegeers CJ
J Recept Res; 1987; 7(1-4):223-39. PubMed ID: 3625598
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of dopamine-D2 and serotonin-S2 receptors by chronic treatment with the serotonin-S2 antagonists, ritanserin, and setoperone.
Leysen JE; van Gompel P; Gommeren W; Laduron PM
Psychopharmacol Ser; 1987; 3():214-24. PubMed ID: 2950521
[No Abstract] [Full Text] [Related]
5. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the serotonin S2-receptor in brain after chronic lithium.
Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A
Neurochem Res; 1986 Jul; 11(7):949-57. PubMed ID: 2944024
[TBL] [Abstract][Full Text] [Related]
7. The dissociation rate of unlabelled drugs from receptor sites: a poorly investigated, yet important aspect in receptor research. Studies on the serotonin-S2 receptor.
Leysen JE; Gommeren W; Van Gompel P
J Recept Res; 1988; 8(1-4):547-59. PubMed ID: 3385693
[TBL] [Abstract][Full Text] [Related]
8. Biochemical profile of risperidone, a new antipsychotic.
Leysen JE; Gommeren W; Eens A; de Chaffoy de Courcelles D; Stoof JC; Janssen PA
J Pharmacol Exp Ther; 1988 Nov; 247(2):661-70. PubMed ID: 2460616
[TBL] [Abstract][Full Text] [Related]
9. 5-HT2 receptors, roles and regulation.
Leysen JE; Pauwels PJ
Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
[TBL] [Abstract][Full Text] [Related]
10. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.
Battaglia G; Shannon M; Titeler M
J Neurochem; 1984 Nov; 43(5):1213-9. PubMed ID: 6491656
[TBL] [Abstract][Full Text] [Related]
11. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
Laduron PM; Janssen PF; Leysen JE
Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
Battaglia G; Norman AB; Newton PL; Creese I
J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
[TBL] [Abstract][Full Text] [Related]
14. In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.
Wouters W; Janssen CG; Van Dun J; Thijssen JB; Laduron PM
J Med Chem; 1986 Sep; 29(9):1663-8. PubMed ID: 3746815
[TBL] [Abstract][Full Text] [Related]
15. Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.
Schotte A; de Bruyckere K; Janssen PF; Leysen JE
Brain Res; 1989 Oct; 500(1-2):295-301. PubMed ID: 2481562
[TBL] [Abstract][Full Text] [Related]
16. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
Altar CA; Kim H; Marshall JF
J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
[TBL] [Abstract][Full Text] [Related]
17. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
Hamblin MW; Leff SE; Creese I
Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
[TBL] [Abstract][Full Text] [Related]
18. Serotonin-S2 and dopamine-D2 receptors are the same size in membranes.
Brann MR
Biochem Biophys Res Commun; 1985 Dec; 133(3):1181-6. PubMed ID: 2935151
[TBL] [Abstract][Full Text] [Related]
19. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
[TBL] [Abstract][Full Text] [Related]
20. Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
Rashid M; Watanabe M; Nakazawa M; Nakamura T; Hattori K; Nagatom T
Jpn J Pharmacol; 2001 Nov; 87(3):189-94. PubMed ID: 11885967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]